The North American dermal fillers market is estimated to grow at a CAGR of 7.0% during the forecast period. The North American market is expected to reach around $2.9 billion in 2025 as compared to nearly $1.8 billion in 2018. Growing minimally invasive procedures has increased the number of cosmetic procedures in the region as the minimally invasive procedure provides faster recovery and better cosmetic results which are contributing to the market growth. Other crucial factors are promoting market growth in the region. This includes a significant rise in the population with the age group, ranging between 18 and 64. For instance, as per the US Census Bureau, in 2017, the total population in the US was 325.7 million, of which 62% was constituted by 18-64 age group people. This, in turn, is contributing to the demand for advanced dermal fillers in the region coupled with increasing consciousness about physical appearance.
Get Free Sample Copy @ https://www.omrglobal.com/request-sample/north-american-dermal-fillers-market
The main objective of dermal filler is to replace the lost volume that causes the cheeks to flatten, marionette lines to form and develop nasolabial folds. The procedure is intended to correct this loss of volume in a natural, subtle way and restore volume to the face. To improve the efficiency of the treatment, the US FDA has approved multiple dermal fillers which are produced from temporary or absorbable material for the correction of moderate to severe facial wrinkles and skin folds, including nasolabial folds. It has approved dermal filler produced from non-absorbable (permanent) material only for the correction of cheek acne scars and nasolabial folds in patients more than the age of 21 years.
Browse for Full Report Description@ https://www.omrglobal.com/industry-reports/north-american-dermal-fillers-market
The North American dermal fillers market is segmented based on application, type, and end-users. Based on application, the market is classified into face-lift, lip treatment/enhancement, facial line correction treatment, and other applications. Based on type, the market is segmented into collagen fillers, poly-L-lactic acid, hyaluronic acid, calcium hydroxylapatite, and others. Based on end-user, the market is segmented into dermatology clinics and hospitals. Among types, the calcium hydroxylapatite is projected to exhibit a significant growth rate in the market due to technology advancement and new product development.
Market Segmentation
By Application
- Face-Lift
- Lip Treatment/Enhancement
- Facial Line Correction Treatment
- Others (Acne Scar Treatment)
By Type
- Collagen Fillers
- Ploy-L-Lactic Acid (PLLA)
- Hyaluronic Acid (HA)
- Calcium Hydroxylapatite (CaHA)
- Others (Autologous Fat Injections and Polymethylmethacrylate (PMMA))
By End-User
- Dermatology Clinics
- Hospitals
Regional Analysis
- United States
- Canada
Company Profiles
- Allergan PLC
- Anika Therapeutics, Inc.
- Croma-Pharma GmbH
- Cynosure LLC
- Galderma Laboratories, L.P.
- Huons Co. Ltd.
- Merz Pharmaceuticals GmbH
- Prollenium Medical Technologies, Inc.
- Sculpt Luxury Dermal Fillers Ltd.
- Suneva Medical, Inc.
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)
